Kiley Juergens Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Kiley Juergens Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$151.91 - $192.21 $43,142 - $54,587	-284 Closed	0 $0
Q3 2018 Oct 10, 2018	BUY	$167.73 - $192.74 $1,509 - $1,734	9 Added 3.27%	284 $54,000
Q2 2018 Jul 23, 2018	BUY	$145.72 - $169.96 $40,073 - $46,739	275 New	275 $0
Q1 2018 Apr 23, 2018	SELL	$151.6 - $177.13 $41,690 - $48,710	-275 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$137.28 - $155.55 $37,752 - $42,776	275	275 $41,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Kiley Juergens Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kiley Juergens Wealth Management, LLC with notifications on news.